科美诊断 (688468)
Chemclin Diagnostics Co., Ltd.
K-Line Chart
No K-line data available
Company NameKemei Diagnostic Technology Co., Ltd.
Listing Date2021-04-09
Issue Price7.15RMB
Registered Capital40110.810k RMB
Legal RepresentativeLi Lin
Registered Address1st and 6th Floors, Incubation Building, Beike Modern Manufacturing Park, No. 7 Fengxian Middle Road, Yongfeng Base, Haidian District, Beijing
IndustryMedical Devices
Main BusinessA high-tech enterprise engaged in the R&D, production, and sales of clinical immuno-chemiluminescence diagnostic reagents and instruments.
Company ProfileBeijing Kemei Biotechnology Co., Ltd. was founded in 2007 and is one of the earliest companies in China specializing in the development of clinical immunology diagnostic products. Kemei Biotechnology focuses on the R&D, production, sales, and service of clinical in vitro diagnostic (IVD) products.
In September 2019, Beijing Kemei Biotechnology Co., Ltd. was restructured and established as Kemei Diagnostic Technology Co., Ltd. (hereinafter referred to as Kemei Diagnostic). Boyang Biotechnology (Shanghai) Co., Ltd., located in Shanghai Zhangjiang Science and Technology City, is a wholly-owned subsidiary of Kemei Diagnostic.
Stock Details
1. Key Indicators
- Total Shares(W): 40110.80
- Circulating A-Shares(W): 40110.80
- Earnings Per Share(RMB): 0.1000
- Net Assets Per Share(RMB): 3.5116
- Operating Revenue(W RMB): 26082.19
- Total Profit(W RMB): 4615.57
- **Net Profit Attributable to Parent(W RMB) **: 4156.28
- Net Profit Growth Rate(%): -62.94
- Weighted Return on Equity(%): 2.9300
- Operating Cash Flow Per Share(RMB): 0.1780
- Undistributed Profit Per Share(RMB): 1.0914
- Capital Reserve Per Share(RMB): 1.4102
2. Main Business
The main business covers:
- Research, development, production, and sales of clinical immuno-chemiluminescence diagnostic testing reagents and instruments.
3. Company Basic Information
- Company Name: Chemclin Biotech Co., Ltd.
- Listing Date: 2021-04-09
- Industry: Pharmaceutical Manufacturing
- Address: 1st Floor, 6th Floor, Incubation Building, Beijing Modern Manufacturing Park, No. 7 Fengxian Middle Road, Yongfeng Base, Haidian District, Beijing
- Website: https://www.chemclin.com
- Company Profile: The company was established as a joint stock company with Beijing Capital Venture Group as the main sponsor. It is primarily engaged in the research, development, production, and sales of clinical immuno-chemiluminescence diagnostic testing reagents and instruments.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Ningbo Bonded Area Envility Enterprise Management Partnership (Limited Partnership) | Corporate Entity | 10800.00 | 26.93 |
| 2 | CICC Kangrui Phase I (Ningbo) Equity Investment Fund Partnership (Limited Partnership) | Corporate Entity | 2271.05 | 5.66 |
| 3 | Ningbo Bonded Area Kebeiao Enterprise Management Partnership (Limited Partnership) | Corporate Entity | 1800.00 | 4.49 |
| 4 | Jiaxing Shenmao No. 3 Equity Investment Partnership (Limited Partnership) | Corporate Entity | 1432.31 | 3.57 |
| 5 | HJ CAPITAL 2 LIMITED | Corporate Entity | 1127.34 | 2.81 |
| 6 | Hangzhou Chuangqian Investment Partnership (Limited Partnership) | Corporate Entity | 1021.98 | 2.55 |
| 7 | Ningbo Meishan Bonded Port Area Huahao Investment Management Partnership (Limited Partnership) | Corporate Entity | 1021.97 | 2.55 |
| 8 | Penghua Quantitative Pioneer Hybrid Securities Investment Fund | Fund | 6.92 | 0.02 |
5. Concept Sectors
- Margin Trading & Securities Lending
- Micro & Small Cap Stocks
Remarks
- Data update date: 2025-09-30
- Data source: Public Market Information